Category: pharma & healthcare

New Data Suggests That 50% Of Omicron Infections In Healthy Young Men Remain Transmissible After Five Days

The study gathered PCR tests from basketball players in the National Basketball Association, aiming to elucidate the viral dynamics of Omicron, namely when viral load peaks and how long the general infection lasts.

New Data Suggests That 50% Of Omicron Infections In Healthy Young Men Remain Transmissible After Five Days

The study gathered PCR tests from basketball players in the National Basketball Association, aiming to elucidate the viral dynamics of Omicron, namely when viral load peaks and how long the general infection lasts.

Inhaled Remdesivir for Home Use for Covid Treatment

For a patient at high risk of severe COVID-19 related complications, newly released data shows that inhaled remdesivir offers the promise of an effective treatment for home use.

Endemic Disease Does Not Necessarily Mean Mild Disease

Many are hoping that the Omicron variant signals a transition into the endemic phase of Covid-19 pandemic. But this hope is based on the flawed logic that endemic equals mild, resulting in less severe disease and fewer deaths.

Tennis Star Chris Evert Teaches Us That Genetic Testing Is A Lifetime Match

Chris Evert’s sister died of ovarian cancer in 2020. Her genetic test results did not reveal a mutation — but that changed, saving Chris’ life.

We Can’t Stop Reporting Covid Cases

Understanding infection rates in our communities is critical knowledge that keeps us safe by allowing us to modify our behavior based on risk.

Time to Expand Vaccination to Infants and Toddlers and Boosters for Children

Innate immune protection against the COVID-19 virus largely spared young children from contracting previous variants. Omicron, however, has unique adaptations that penetrate natural immunity, leading to record rates of infection and hospitalization amo…

Medicare Proposes Restricting Coverage Of Aduhelm To Alzheimer’s Patients Who Enroll In Clinical Trials

On January 11, Medicare issued a draft memorandum that it will only pay for Aduhelm under the so-called coverage with evidence development (CED) pathway. On one hand, proponents say Medicare can learn whether the drug works in the context of a CED stud…

Omicron: Less Virulent But Still Dangerous

A recent study found that Omicron is less virulent in mouse and hamster models.

The Case For Third And Fourth Booster Shots

A third dose of the mRNA vaccines is one tool that can be deployed swiftly to save lives and hospital beds.